{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-097603","form_type":"8-K","ticker":"XLO","cik":"0001840233","company_name":"Xilio Therapeutics, Inc.","filed_at":"2026-03-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.482788+00:00","generated_at":"2026-05-15T18:08:40.586520+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Xilio Therapeutics posts corporate investor presentation; no new data in filing excerpt","bullets":["Slide deck titled 'Unlocking the Potential of Immuno-Oncology Therapies' dated March 9, 2026.","Presentation made available on company's website; no specific pipeline or financial details provided in this extract.","Regulatory filing solely covers Reg FD disclosure of routine investor materials."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-097603","json":"https://secwatch.observer/filing/0001193125-26-097603.json","markdown":"https://secwatch.observer/filing/0001193125-26-097603.md","text":"https://secwatch.observer/filing/0001193125-26-097603.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840233/000119312526097603/0001193125-26-097603-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840233/000119312526097603/xlo-20260309.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T18:08:40.586520+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}